Gibson, T.’s team published research in Advances in Experimental Medicine and Biology in 1980 | CAS: 40180-04-9

Advances in Experimental Medicine and Biology published new progress about Gout. 40180-04-9 belongs to class benzothiophene, name is 2-(2,3-Dichloro-4-(thiophene-2-carbonyl)phenoxy)acetic acid, and the molecular formula is C13H8Cl2O4S, Recommanded Product: 2-(2,3-Dichloro-4-(thiophene-2-carbonyl)phenoxy)acetic acid.

Gibson, T. published the artcileTienilic acid in the treatment of gout and hypertension, Recommanded Product: 2-(2,3-Dichloro-4-(thiophene-2-carbonyl)phenoxy)acetic acid, the main research area is tienilic acid gout hypertension; health hazard tienilic acid.

Tienilic acid (I) [40180-04-9] (125 mg, twice daily) was given to patients with hypertension and gouty arthritis. In hypertensive patients, the supine and standing diastolic values declined progressively from 101 to 92 and 102 to 94 mm/Hg resp., over a period of 4 wk. There was a significant decrease in serum uric acid and K. I decreased hyperuricemic levels in gouty patients by 50%. Precipitation of acute gout by I probably reflects its profound effect on blood uric acid levels.

Advances in Experimental Medicine and Biology published new progress about Gout. 40180-04-9 belongs to class benzothiophene, name is 2-(2,3-Dichloro-4-(thiophene-2-carbonyl)phenoxy)acetic acid, and the molecular formula is C13H8Cl2O4S, Recommanded Product: 2-(2,3-Dichloro-4-(thiophene-2-carbonyl)phenoxy)acetic acid.

Referemce:
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem